Detalles de la búsqueda
1.
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.
Circulation
; 148(5): 381-390, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37356038
2.
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.
Ann Intern Med
; 176(4): 515-523, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36940444
3.
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
JAMA
; 327(3): 227-236, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35040887
4.
High-risk subgroups were not identified to benefit from thromboprophylaxis after hospitalization for COVID-19.
Res Pract Thromb Haemost
; 8(4): 102417, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38859949
5.
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life.
Chest
; 165(4): 785-799, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37979717
6.
Comment on Viderman et al. Remote Monitoring of Chronic Critically Ill Patients after Hospital Discharge: A Systematic Review. J. Clin. Med. 2022, 11, 1010.
J Clin Med
; 12(20)2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37892570
7.
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.
JAMA Netw Open
; 6(5): e2314428, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227729
8.
Anticoagulant Therapy in Patients Hospitalized With COVID-19.
JAMA Intern Med
; 181(12): 1621-1622, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34617968
Resultados
1 -
8
de 8
1
Próxima >
>>